In 2023, Costa Rica recorded a life expectancy of approximately 80 years—roughly matching or exceeding the United States. Its per capita health expenditure hovers around $1,200 annually. The US spends over $12,000. This is not a rounding error. It is a systemic divergence that demands serious comparative analysis, because it challenges the foundational assumption that health outcomes scale with spending.

The conventional wisdom in high-income health policy circles holds that better outcomes require more technology, more specialists, and more infrastructure. Costa Rica's Equipos Básicos de Atención Integral en Salud—known as EBAIS—offers a direct rebuttal. Built on community-based primary care teams serving defined populations, the system achieves extraordinary coverage and outcomes through strategic resource allocation rather than resource abundance.

What makes the Costa Rican case particularly instructive is not just the health metrics. It is the political economy behind them. This is a country that abolished its military in 1948 and redirected those funds toward education and health. The system was not conjured overnight—it was constructed through decades of deliberate institutional investment, social consensus, and a willingness to prioritize primary care when most nations were chasing tertiary sophistication. Understanding how EBAIS works, and why it works, offers system design lessons that transcend income brackets.

The EBAIS model assigns a multidisciplinary team—typically a physician, a nurse, a pharmacy technician, and a community health worker known as an asistente técnico de atención primaria (ATAP)—to a geographically defined population of roughly 4,000 to 5,000 people. This is not a clinic you visit when sick. It is a team that knows your household, tracks your chronic conditions, and follows up when you miss an appointment.

The ATAP role is the most distinctive feature of this architecture. These community health workers conduct regular home visits—door to door, across their assigned sector. They carry census data, immunization records, and screening checklists. They identify pregnant women early, monitor growth in children under five, and flag adults with uncontrolled hypertension or diabetes. This is proactive population health management executed at the ground level, not algorithmic risk stratification running on a hospital server.

What this structure achieves is continuity of care embedded in geography. Patients do not navigate a fragmented referral maze. Their primary care team knows them longitudinally. When escalation to a specialist or hospital is necessary, it flows through a structured referral network managed by the Caja Costarricense de Seguro Social (CCSS), the single-payer institution that finances and operates the system. The EBAIS team remains the anchor.

This model also creates a natural feedback loop for resource allocation. Because each team is responsible for a defined population, epidemiological data flows upward with precision. National health planners know where maternal mortality clusters, where dengue outbreaks begin, and where diabetes prevalence is rising—not from periodic surveys, but from continuous community-level surveillance built into routine care delivery.

Critics sometimes argue that the EBAIS model works only because Costa Rica is small. But the structural principle—assigning multidisciplinary teams to defined populations with proactive outreach—is scale-neutral. Thailand's community health volunteer system and Brazil's Estratégia Saúde da Família independently adopted remarkably similar designs, suggesting that the underlying logic is robust across vastly different contexts.

Takeaway

Health systems that assign responsibility for defined populations to integrated primary care teams generate better outcomes not because they spend more, but because they see problems before those problems become expensive.

Costa Rica's immunization coverage consistently exceeds 95% for key childhood vaccines—a figure that many OECD nations struggle to maintain. Its maternal mortality ratio has dropped dramatically over decades, driven by near-universal prenatal care access facilitated through EBAIS. These are not boutique achievements. They are the predictable outputs of a system designed around prevention as its primary economic strategy, not merely its public health aspiration.

The distinction matters enormously. In systems oriented around acute and specialty care, prevention is an add-on—a line item in a budget dominated by hospital reimbursement and procedural volume. In Costa Rica's model, prevention is the system's center of gravity. Resources flow first to vaccination campaigns, prenatal monitoring, well-child visits, and chronic disease management. Hospitals exist for escalation, not as the default site of care delivery.

Consider the economics of chronic disease. The EBAIS model catches hypertension early through routine community screening. An ATAP identifies an at-risk individual during a home visit, the primary care physician initiates treatment with generic antihypertensives that cost cents per day, and the team monitors adherence over time. Compare this with the US trajectory: hypertension undetected for years, presenting as a stroke or myocardial infarction requiring $100,000 in acute care, followed by costly rehabilitation and permanent disability.

Costa Rica's approach to chronic disease is particularly relevant as non-communicable diseases become the dominant burden globally. The country has not eliminated diabetes or cardiovascular disease. But by catching these conditions early and managing them in primary care settings, it avoids the catastrophic downstream costs that consume an outsized share of health expenditure in specialist-heavy systems.

This prevention-first orientation also shapes how Costa Rica trains and deploys its health workforce. Medical education emphasizes primary care and community medicine. Specialists exist and are valued, but the career pipeline does not systematically devalue generalist practice—a structural distortion that plagues workforce planning in the United States, the United Kingdom, and many other high-income systems.

Takeaway

Prevention is not a moral virtue bolted onto a treatment-oriented system. In Costa Rica's design, it is the economic engine—the mechanism by which modest inputs generate disproportionate health returns.

In 1948, Costa Rica's post-civil-war government made a decision that would define the country's development trajectory for the next eight decades: it abolished the national military and constitutionally redirected those resources toward education and health. This was not a health policy decision in isolation. It was a societal compact—a collective agreement that human development would take precedence over military capacity. The health system that emerged was both product and beneficiary of this compact.

The Caja Costarricense de Seguro Social, established in 1941 and expanded dramatically in subsequent decades, became the institutional vehicle for this commitment. Funded through payroll contributions from employers, employees, and the state, the CCSS operates as both insurer and provider. This vertical integration—unusual even among single-payer systems—gives planners direct control over resource allocation, workforce deployment, and facility investment. It eliminates the fragmentation that characterizes systems with multiple payers negotiating with independent providers.

Crucially, this political commitment has survived across administrations of vastly different ideological orientations. Costa Rica's health system is not the legacy of a single party or leader. It has been maintained by governments of the center-left and center-right alike, suggesting that the social consensus around health investment transcends partisan politics. This durability is itself a design lesson: systems that generate visible, broadly shared benefits create their own political constituencies.

The system is not without challenges. Wait times for specialty care have lengthened. The CCSS faces fiscal pressures as the population ages and chronic disease prevalence rises. Private-sector utilization is growing among wealthier Costa Ricans frustrated with public-sector delays. These are real tensions, and they require honest analysis rather than idealization.

But the essential point remains. Costa Rica demonstrates that a middle-income country can achieve population health outcomes that rival or exceed those of nations spending ten times more—if the political system sustains investment in primary care, prevention, and universal coverage over decades. The constraint is not money. It is political will, institutional continuity, and the willingness to organize a health system around population needs rather than provider revenue.

Takeaway

The most powerful determinant of a health system's performance is not its budget—it is the political durability of the commitment to invest that budget in primary care, prevention, and universal access.

Costa Rica's EBAIS system is not a curiosity of tropical exceptionalism. It is a working proof of concept that primary care-centered, prevention-oriented health system design generates superior population outcomes at a fraction of the cost demanded by specialist-driven models. The mechanisms are well understood: defined populations, proactive community outreach, structured referral networks, and continuous epidemiological feedback.

The harder lesson is political, not technical. Costa Rica built this system because it made a sustained societal choice to prioritize health investment—a choice reinforced across decades and administrations. The system persists not because it is perfect but because it delivers visible returns to a broad population that, in turn, defends it.

For health system leaders and policymakers in high-income countries struggling with unsustainable costs and stagnating outcomes, the Costa Rican case does not offer a template for direct replication. It offers something more uncomfortable: evidence that the primary barrier to better health outcomes is not insufficient resources but misallocated ones.